Behavior of renal disorders in pediatric patients with drepanocytosis
Keywords:
kidney diseases, anemia, sickle cell, childAbstract
Introduction: the drepanocytosis is a disease with multisystem impact. Renal disease begins in childhood and chronic consequences are glomerulopathy sickle glomerular with evolution to chronic renal failure. Objective: to know how renal disorders are expressed in pediatric patients with drepanocytosis. Method: a prospective descriptive study was realized in pediatric patients with drepanocytosis attended in the outpatient of Hematology at “José Luis Miranda” Hospital between August 2013 and December 2014. Sixteen asymptomatic patients were included in the last month without transfused in the previous three months. Clinical variables, hematological, biochemical and imaging were evaluated in order to describe the renal abnormalities. Results: three patients with positive microalbuminuria were diagnosed; the average age was 13 years, the hemoglobinopathy SS was the most frequent, significant differences were found in terms of fetal hemoglobin, which was higher in patients with negative microalbuminuria, with a 6,6 average. The urinary density showed an average of 1 014,6 for patients with negative microalbuminuria and 1 008,0 for those who had positive, significant differences were found. In patients with positive microalbuminuria the most frequent crisis was the acute chest syndrome (100%). Conclusions: the frequency of positive microalbuminuria behaved similar to some reviewed studies, an average age of 13 years was evident for these cases with count of higher reticulocytes, lower urinary density and higher frequency of abnormalities of the urinary sediment and acute chest syndrome of the rest of the group studied; most of them were undernourished.Downloads
References
1. Svarch E, Marcheco-Teruel B, Machín-García S, Menéndez-Veitía A, Nordet-Carrera I, Arencibia-Núñez A, et al. La drepanocitosis en Cuba. Estudio en niños. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2011 [citado 5 May 2015];27(1):51-67. Disponible en: http://scielo.sld.cu/pdf/hih/v27n1/hih05111.pdf
2. Svarch E. Programa cubano de atención integral al paciente con drepanocitosis. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2011 [citado 14 Nov 2014];27(2):165-167. Disponible en: http://scielo.sld.cu/pdf/hih/v27n2/hih01211.pdf
3. Riehm Meier E, Miller JL. Sickle cell disease in children. Drugs [Internet]. 2012 [citado 15 Jun 2014];72(7):895-906. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899685/
4. López Revuelta K, Ricard Andrés MP. Afectación renal en la enfermedad falciforme. Nefrología (Madr.) [Internet]. 2011 [citado 19 Jun 2014]; 31(5):591-601. Disponible en: http://www.revistanefrologia.com/es-publicacion-nefrologia-articulo-afectacion-renal-enfermedad-falciforme-X0211699511052490
5. Núñez-Quintana A, Hondal-Álvarez NI, Ayllón-Valdés L. Alteraciones renales en la drepanocitosis. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2011 [citado 22 May 2015];27(2):168-178. Disponible en: http://scielo.sld.cu/pdf/hih/v27n2/hih02211.pdf
6. Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol [Internet]. 2011 [citado 27 Jun 2015];26:1285. Disponible en: http://health.springer.com/article/10.1007/s00467-011-1857-2/fulltext.html
7. Becker AM. Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol [Internet]. 2011 [citado 23 Jun 2015];26(12):2099-2109. Disponible en: http://health.springer.com/article/10.1007/s00467-010-1736-2/fulltext.html
8. Ranque B, Menet A, Diop IB, Thiam MM, Diallo D, Diop S, et al. Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study. Lancet Hematol [Internet]. 2014 [citado 11 Jun 2015];1(2):e64-e73. Disponible en: http://www.thelancet.com/journals/lanhae/article/PIIS2352-3026%2814%2900007-6/fulltext
9. Aloni MN, Ngiyulu RM, Gini-Ehungu JL, Nsibu NC, Ekila MB, Lepira FB, et al. Renal function in children suffering from sickle cell disease: challenge of early detection in highly resource- scarce settings. PloS One [Internet]. 2014 [citado 12 Jun 2015];9(5):e96561. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014510/
10. Oña Aldama N, Díaz de Armas M, Rebull Pradas A, Russeaux Guía N. Estrategias para la introducción de nuevos diagnosticadores en el Sistema Nacional de Salud. Rev Cubana Farmac [Internet]. 2015 [citado 8 Ene 2016];49(2):197-208. Disponible en: http://scielo.sld.cu/pdf/far/v49n2/far02215.pdf
11. Ministerio de Salud Pública. Umelisa microalbúmina. Para la cuantificación de albúmina humana en muestras de orina. La Habana: Centro de Inmunoensayo; 2009.
12. King L, MooSang M, Miller M, Reid M. Prevalence and predictors of microalbuminuria in Jamaican children with sickle cell disease. Arch Dis Child [Internet]. 2011 [citado nov 2014];96(12):[aprox. 3 p.]. Disponible en: http://adc.bmj.com/content/early/2011/09/30/archdischild-2011-300628.abstract
13. Asnani MR, Fraser RA, Reid ME. Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease. PLoS One [Internet]. 2011 [citado junio 2015];6(4)e18863. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077410/pdf/pone.0018863.pdf
14. Mawanda M, Ssenkusu JM, Odiit A, Kiguli S, Muyingo A, Ndugwa C. Micro-albuminuria in Ugandan children with sickel cell anaemia: a cross-sectional study. Ann Trop Paediatr [Internet]. 2011 [citado 8 Jun 2015]; 31. Disponible en: http://tandfonline.com/doi/abs/10.1179/1465328111Y.0000000013?journalCode=ypch19
15. Osei-Yeboah CT, Rodrigues O. Renal status of children with sickle cell disease in Accra, Ghana. Ghana Med J [Internet]. 2011 [citado 8 Jun 2015];45(4):155-160. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283093/
16. Bodas P, Huang A, O’Riordan MA, Sedor JR, Dell KM. The prevalence of hypertension and abnormal kidney function in children with sickle cell disease –a cross sectional review. BMC Nephrology [Internet]. 2013 [citado 11 Jun 2014];14(1):237. Disponible en: http://health.springer.com/article/10.1186/1471-2369-14-237/fulltext.html
17. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev [Internet]. 2007 [citado 8 Jun 2014];21(1):37-47. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048670/
18. Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, Ware RE. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia. Am J Hematol [Internet]. 2013 [citado 10 Jun 2015];88(2):116-119. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/ajh.23365/full
19. Creary S, Zickmund S, Ross D, Krishnamurti L, Bogen DL. Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision. BMC Res Notes [Internet]. 2015 [citado 28 Sept 2015];8:372. Disponible en: http://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-015-1344-0
20. Shome DK, Al Ajmi A, Radhi AA, Mansoor EJ, Majed KS. The effect of hydroxyurea therapy in bahraini sickle cell disease patients. Indian J Hematol Blood Transfus [Internet]. 2016 [citado 28 Sept 2015];32:104. Disponible en: http://link.springer.com/article/10.1007%2Fs12288-015-0529-y#page-1
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
15 junio 2025
